Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative Canada

Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative

Ottawa, Canada
CBIC funds Canadian genomics innovation for commercialization
grant_single_labels|summary
grant_single_labels|preview
grant_single_labels|projects
grant_single_labels|admissibility
grant_single_labels|criteria
grant_single_labels|register
grant_single_labels|otherInfo

grant_single_labels|summary

grant_single|eligibleFinancing
  • grant_single|fromMinToMax
  • grant_single|projectCostPercent
grant_single|deadlines
  • grant_single|openingDateAugust 01, 2024
  • grant_single|closingDateMarch 17, 2025
grant_single|financingType
Grant and Funding
grant_single|eligibleIndustries
  • Manufacturing
  • Professional, scientific and technical services
  • Health care and social assistance
grant_single|grantors
  • Genome Prairie
  • Genome Canada
grant_single|status
grant_card_status|open

grant_single_labels|preview

The Canadian Biotechnology Innovation and Commercialization (CBIC) initiative provides funding of up to $2 million to support public-private research and development projects focused on the commercialization of genomics and biotechnology innovations. Eligible activities include innovation R&D from invention to proof of concept through prototype demonstration, aiming to generate significant social and economic impact for Canadian stakeholders.

grant_single_labels|projects

The Canadian Biotechnology Innovation and Commercialization (CBIC) initiative supports research and development activities that promote innovation and address real-world opportunities in the field of genomics and biotechnology. Eligible projects must partner public and private entities to achieve significant socio-economic impacts.
  • Research and development activities focusing on innovation from invention to proof of concept through prototype demonstration, specifically within genomics and biotechnology.
  • Projects that result in the development or application of a genomics-based product, process, or service solution addressing industry-defined opportunities or challenges.
  • Collaborative initiatives co-led by Researchers and Receptors, targeting technological innovation and commercialization through cooperative public-private R&D.

grant_single_labels|admissibility

Eligibility for this grant requires that the lead Receptor meet specific criteria related to their organizational status and activities within Canada.
  • The lead Receptor must be a Canadian for-profit entity domiciled in Canada, whether public or privately held.
  • Alternatively, the lead Receptor can be a foreign for-profit entity with business operations in Canada, such as producing goods or services or conducting R&D within Canada.
  • An industry consortia or a non-profit organization that will provide the innovation to Canadian for-profit entities can also qualify as a lead Receptor.
  • Preference is given to Canadian-domiciled for-profit entities over those headquartered outside of Canada.
  • The project must be co-led by an eligible Researcher and a senior representative from the Receptor organization.
  • The project partners must have clearly defined roles and responsibilities, integrating their expertise and resources.
  • The Receptor organization must not be solely funded or primarily funded by public sources.

grant_eligibility_criteria|who_can_apply

The Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative is a funding opportunity for certain types of organizations engaged in genomics and biotechnology research and commercialization. This program specifically targets public-private research partnerships with a focus on innovation and commercialization in genomics.
  • Canadian public and private institutions involved in genomics-related innovation R&D.
  • Projects co-led by a Researcher & Receptor that addresses a Receptor-defined opportunity or challenge.
  • Canadian-domiciled for-profit entities acting as lead Receptors, with foreign companies potentially eligible if they have operations in Canada.

grant_eligibility_criteria|eligible_expenses

The grant covers specific expenses that are directly related to the project's success, including limited equipment purchases and services essential to achieving project goals.
  • Individual equipment items with costs less than or equal to $100,000 per item; more expensive items assessed case-by-case.
  • Collective use of Genome Canada funds for equipment not exceeding ten percent (10%) of the approved Genome Canada funding.
  • Services from others with a total cost less than or equal to twenty-five percent (25%) of the total budget; higher amounts assessed case-by-case.

grant_eligibility_criteria|zone

Eligible companies for this grant must be operating with a significant presence in Canada. The locations are defined specifically to benefit Canadian industrial and technological advancements.
  • Canadian-domiciled for-profit entities.
  • Foreign for-profit entities with business operations in Canada.

grant_single_labels|criteria

The evaluation and selection of projects for the CBIC initiative are based on the potential socio-economic benefits, the project's alignment with the initiative's objectives, and its feasibility and risk management strategies.
  • Potential socio-economic impact and benefits for Canadian stakeholders.
  • Feasibility of the proposed product, process, or service solution.
  • Clear analysis of the market opportunity being addressed.
  • Comprehensive risk-mitigation plan addressing potential project barriers, including technical, social, market, regulatory, and competition.
  • Extent of technological innovation and contribution to advancing Canadian genomics and biotechnology sectors.
  • Alignment with the inclusivity and diversity principles, specifically encouraging participation from underrepresented communities.

grant_single_labels|register

  • Step 1: Submission of Letter of Intent (LOI)
  • Draft a summary of the proposed project and its value proposition.
  • Include a description of the technical opportunity or solution, market opportunity, commercialization plan, and potential socio-economic impact.
  • Submit the LOI to Genome Canada through your regional Genome Centre.
  • Await notification from Genome Canada regarding the eligibility of your project, which will be communicated within 10 business days of submission.
  • Step 2: Preparation of Full Application
  • Develop a detailed explanation of the project's research, development, and commercialization plan.
  • Prepare a comprehensive budget outline for the project.
  • Ensure adherence to the intellectual property, co-funding, and inclusion criteria as per Genome Canada guidelines.
  • Step 3: Submission of Full Application
  • Submit the detailed full application to Genome Canada through your regional Genome Centre.
  • Ensure completeness and accuracy of all submitted documents to meet Genome Canada’s requirements.
  • Step 4: Review and Recommendations
  • Your application will be initially reviewed by a panel of external experts.
  • The Genome Canada Oversight and Review Committee (ORC) will assess the proposal package along with expert reviews.
  • The ORC will provide funding recommendations to Genome Canada’s Board of Directors.
  • Step 5: Final Decision
  • The Board of Directors of Genome Canada will make the final funding decision.
  • Confirm receipt of decision and, if approved, prepare to comply with all requirements for funding management and project reporting.

grant_single_labels|otherInfo

Here are additional relevant details for this grant:
  • An IP term sheet or broader agreement must be legally binding and signed before the release of funds.
  • The Data Release and Resource Sharing Plan is mandatory and aligns with Genome Canada's policies balancing commercial confidentiality and openness.
  • All reviewers and Oversight and Review Committee members are bound by confidentiality and conflict of interest agreements.
  • Genome Canada encourages projects to include individuals from under-represented communities in leadership positions.
  • Projects with Indigenous involvement should adhere to principles of Indigenous data governance and respect cultural sensitivities as specified in the Tri-Council Policy Statement.
  • Progress reports are generally required semi-annually, but some projects might need more frequent reporting as deemed necessary.
  • The Oversight and Review Committee will assess progress reports to determine if funding should continue, be modified, or terminated.

Apply to this program

More grants like this